Rothman Orthopaedic Institute, Thomas Jefferson University, Philadelphia, Pennsylvania.
J Bone Joint Surg Am. 2022 Jan 19;104(2):160-165. doi: 10.2106/JBJS.20.01585.
A large body of evidence is emerging to implicate that dysregulation of the gut microbiome (dysbiosis) increases the risk of surgical site infections. Gut dysbiosis is known to occur in patients with inflammatory bowel disease (IBD), allowing for translocation of bacteria across the inflamed and highly permeable intestinal mucosal wall. The null hypothesis was that IBD was not associated with an increased risk of periprosthetic joint infection (PJI) after primary total hip and knee arthroplasty.
A matched cohort study was designed. The primary end point was the occurrence of PJI at 2 years postoperatively. The secondary end points were aseptic revisions at 2 years postoperatively, discharge to a rehabilitation facility, complications up to 30 days after total joint arthroplasty, and readmission up to 90 days after total joint arthroplasty. The International Classification of Diseases, Ninth Revision (ICD-9) and Tenth Revision (ICD-10) codes were used to identify patients with IBD and the control cohort. A chart review was performed to confirm the diagnosis of IBD. Using our institutional database, 152 patients with IBD were identified and matched (3:1) for age, sex, body mass index, year of surgical procedure, Charlson Comorbidity Index, and involved joint with 456 patients without IBD undergoing total joint arthroplasty.
The cumulative incidence of PJI was 4.61% for the patients with IBD compared with 0.88% for the control cohort (p = 0.0024). When univariable Cox regression was performed, a diagnosis of IBD was found to be an independent risk factor for PJI (hazard ratio [HR], 5.44 [95% confidence interval (CI), 1.59 to 18.60]; p = 0.007) and aseptic revisions (HR, 4.02 [95% CI, 1.50 to 10.79]; p = 0.006). The rate of postoperative complications was also higher in patients with IBD.
Based on the findings of this study, it appears that patients with IBD are at higher risk for treatment failure due to PJI or aseptic loosening after primary total joint arthroplasty. The exact reason for this finding is not known, but could be related to bacterial translocation from the inflamed intestinal mucosa, the dysregulated inflammatory status of these patients, malnutrition, and potentially other factors. Some of the aseptic failures could be as a result of infection that may have escaped detection and/or recognition.
Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
大量证据表明,肠道微生物组的失调(生态失调)会增加手术部位感染的风险。已知炎症性肠病(IBD)患者会出现肠道生态失调,从而使细菌穿过发炎且高度渗透的肠黏膜壁易位。本研究的零假设是,IBD 与初次全髋关节和全膝关节置换术后假体周围关节感染(PJI)的风险增加无关。
设计了匹配队列研究。主要终点是术后 2 年时发生 PJI。次要终点是术后 2 年时无菌翻修、出院至康复设施、全关节置换术后 30 天内并发症以及全关节置换术后 90 天内再入院。使用国际疾病分类,第九版(ICD-9)和第十版(ICD-10)代码来确定 IBD 患者和对照组。进行图表审查以确认 IBD 的诊断。使用我们的机构数据库,确定了 152 名 IBD 患者,并按年龄、性别、体重指数、手术年份、Charlson 合并症指数和受累关节进行 3:1 匹配,共 456 名无 IBD 的患者接受了全关节置换术。
IBD 患者的 PJI 累积发生率为 4.61%,而对照组为 0.88%(p=0.0024)。当进行单变量 Cox 回归时,发现 IBD 诊断是 PJI(危险比[HR],5.44[95%置信区间(CI),1.59 至 18.60];p=0.007)和无菌翻修(HR,4.02[95%CI,1.50 至 10.79];p=0.006)的独立危险因素。IBD 患者的术后并发症发生率也较高。
根据本研究的结果,似乎 IBD 患者在初次全关节置换术后因 PJI 或无菌松动而导致治疗失败的风险更高。造成这种发现的确切原因尚不清楚,但可能与来自发炎的肠黏膜的细菌易位、这些患者的失调的炎症状态、营养不良以及潜在的其他因素有关。一些无菌失败可能是由于感染而导致的,这些感染可能未被检测到和/或识别到。
预后 III 级。有关证据水平的完整描述,请参见作者说明。